Barrett & Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-275
Closed -$21.5K – 699
2026
Q2
$21.5K Buy
+275
New +$22.2K 0.01% 422
2025
Q3
– Sell
-249
Closed -$21.7K – 651
2025
Q2
$21.7K Buy
+249
New +$21.1K 0.01% 402
2023
Q4
– Sell
-149
Closed -$11.7K – 630
2023
Q3
$11.7K Buy
+149
New +$12.5K 0.01% 404

Other funds holding MDT

Barrett & Company's MDT Position: Q3 2026 in Review

Barrett & Company sold out of Medtronic (MDT) in Q3 2026, closing a stake of 275 shares — an estimated $21.5K sold.

Barrett & Company first reported a position in MDT in Q3 2023 and held it in 3 quarters. The position peaked at $21.7K in Q2 2025. 2,189 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Barrett & Company reported no remaining Medtronic position as of Q3 2026 after selling out during the quarter.
  • Barrett & Company sold 275 Medtronic shares in Q3 2026, an estimated $21.5K.
  • Barrett & Company first reported a position in Medtronic in Q3 2023 and held it in 3 quarters.
  • Barrett & Company's Medtronic position peaked at $21.7K in Q2 2025.
  • 2,189 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.